{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:08:44Z","timestamp":1792292924273,"version":"4.4.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2008,2,2]],"date-time":"2008-02-02T00:00:00Z","timestamp":1201910400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s10875-008-9171-x","type":"journal-article","created":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T21:39:01Z","timestamp":1201901941000},"page":"62-66","source":"Crossref","is-referenced-by-count":90,"title":["Autoimmunity in Hyper-IgM Syndrome"],"prefix":"10.1007","volume":"28","author":[{"given":"Adriana A.","family":"Jesus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto J. S.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o B.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,2,2]]},"reference":[{"key":"9171_CR1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1365-2249.2000.01142.x","volume":"120","author":"LD Notarangelo","year":"2000","unstructured":"Notarangelo LD, Hayward AR. X-linked immunodeficiency with hyper-IgM (XHIM). Clin Exp Immunol 2000;120:399\u2013405.","journal-title":"Clin Exp Immunol"},{"key":"9171_CR2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.0105-2896.2005.00229.x","volume":"203","author":"V Lougaris","year":"2005","unstructured":"Lougaris V, Badolato R, Ferrari S, Plebani A. Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features. Immunol Rev 2005;203:48\u201366.","journal-title":"Immunol Rev"},{"key":"9171_CR3","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1084\/jem.20062287","volume":"204","author":"M Herv\u00e9","year":"2007","unstructured":"Herv\u00e9 M, Isnardi I, Ng YS, Bussel JB, Ochs HD, Cunningham-Rundles C, et al. CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance. J Exp Med 2007;204:1583\u201393.","journal-title":"J Exp Med"},{"key":"9171_CR4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1084\/jem.183.1.159","volume":"183","author":"S Hess","year":"1996","unstructured":"Hess S, Engelmann H. A novel function of CD40: induction of cell death in transformed cells. J Exp Med 1996;183:159\u201367.","journal-title":"J Exp Med"},{"key":"9171_CR5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1203\/01.PDR.0000139318.65842.4A","volume":"56","author":"A Etzioni","year":"2004","unstructured":"Etzioni A, Ochs HD. The hyper IgM syndrome\u2014an evolving story. Pediatr Res 2004;56:519\u201325.","journal-title":"Pediatr Res"},{"key":"9171_CR6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-3476(97)70123-9","volume":"131","author":"J Levy","year":"1997","unstructured":"Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 1997;131:47\u201354.","journal-title":"J Pediatr"},{"key":"9171_CR7","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.4049\/jimmunol.154.12.6624","volume":"154","author":"F Facchetti","year":"1995","unstructured":"Facchetti F, Appiani C, Salvi L, Levy J, Notarangelo LD. Immunohistologic analysis of ineffective CD40\u2013CD40 ligand interaction in lymphoid tissues from patients with X-linked immunodeficiency with hyper-IgM. Abortive germinal center cell reaction and severe depletion of follicular dendritic cells. J Immunol 1995;154:6624\u201333.","journal-title":"J Immunol"},{"key":"9171_CR8","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1182\/blood.V92.7.2421","volume":"92","author":"K Seyama","year":"1998","unstructured":"Seyama K, Nonoyama S, Gangsaas I, Hollenbaugh D, Pabst HF, Aruffo A, et al. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood 1998;92:2421\u201334.","journal-title":"Blood"},{"key":"9171_CR9","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jaci.2006.01.043","volume":"117","author":"LD Notarangelo","year":"2006","unstructured":"Notarangelo LD, Lanzi G, Peron S, Durandy A. Defects of class-switch recombination. J Allergy Clin Immunol 2006;117:855\u201364.","journal-title":"J Allergy Clin Immunol"},{"key":"9171_CR10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jlb.67.1.2","volume":"67","author":"C Kooten van","year":"2000","unstructured":"van Kooten C, Banchereau J. CD40\u2013CD40 ligand. J Leukoc Biol 2000;67:2\u201317.","journal-title":"J Leukoc Biol"},{"key":"9171_CR11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2567.2006.02520.x","volume":"120","author":"E Hoeyveld Van","year":"2007","unstructured":"Van Hoeyveld E, Zhang PX, De Boeck K, Fuleihan R, Bossuyt X. Hyper-immunoglobulin M syndrome caused by a mutation in the promotor for CD40L. Immunology 2007;120:497\u2013501.","journal-title":"Immunology"},{"key":"9171_CR12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1385\/IR:27:2-3:185","volume":"27","author":"RQ Cron","year":"2003","unstructured":"Cron RQ. CD154 transcriptional regulation in primary human CD4 T cells. Immunol Res 2003;27:185\u2013202.","journal-title":"Immunol Res"},{"key":"9171_CR13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/01.bor.0000231905.12172.b5","volume":"18","author":"A Durandy","year":"2006","unstructured":"Durandy A, Peron S, Fischer A. Hyper-IgM syndromes. Curr Opin Rheumatol 2006;18:369\u201376.","journal-title":"Curr Opin Rheumatol"},{"key":"9171_CR14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.0105-2896.2005.00222.x","volume":"203","author":"A Durandy","year":"2005","unstructured":"Durandy A, Revy P, Imai K, Fischer A. Hyper-immunoglobulin M syndromes caused by intrinsic B-lymphocyte defects. Immunol Rev 2005;203:67\u201379.","journal-title":"Immunol Rev"},{"key":"9171_CR15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0092-8674(00)00079-9","volume":"102","author":"P Revy","year":"2000","unstructured":"Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 2000;102:565\u201375.","journal-title":"Cell"},{"key":"9171_CR16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/85277","volume":"2","author":"A Jain","year":"2001","unstructured":"Jain A, Ma CA, Liu S, Brown M, Cohen J, Strober W. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol 2001;2:223\u20138.","journal-title":"Nat Immunol"},{"key":"9171_CR17","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/00002281-200307000-00009","volume":"15","author":"AV Gulino","year":"2003","unstructured":"Gulino AV, Notarangelo LD. Hyper IgM syndromes. Curr Opin Rheumatol 2003;15:422\u20139.","journal-title":"Curr Opin Rheumatol"},{"key":"9171_CR18","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.4049\/jimmunol.162.9.5601","volume":"162","author":"S Lacroix-Desmazes","year":"1999","unstructured":"Lacroix-Desmazes S, Resnick I, Stahl D, Mouthon L, Espanol T, Levy J, et al. Defective self-reactive antibody repertoire of serum IgM in patients with hyper-IgM syndrome. J Immunol 1999;162:5601\u20138.","journal-title":"J Immunol"},{"key":"9171_CR19","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1086\/515633","volume":"178","author":"K Seyama","year":"1998","unstructured":"Seyama K, Kobayashi R, Hasle H, Apter AJ, Rutledge JC, Rosen D, et al. Parvovirus B19-induced anemia as the presenting manifestation of X-linked hyper-IgM syndrome. J Infect Dis 1998;178:318\u201324.","journal-title":"J Infect Dis"},{"key":"9171_CR20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.md.0000100046.06009.b0","volume":"82","author":"JA Winkelstein","year":"2003","unstructured":"Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore) 2003;82:373\u201384.","journal-title":"Medicine (Baltimore)"},{"key":"9171_CR21","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/1529-0131(199906)42:6<1291::AID-ANR29>3.0.CO;2-#","volume":"42","author":"EA Webster","year":"1999","unstructured":"Webster EA, Khakoo AY, Mackus WJ, Karpusas M, Thomas DW, Davidson A, et al. An aggressive form of polyarticular arthritis in a man with CD154 mutation (X-linked hyper-IgM syndrome). Arthritis Rheum 1999;42:1291\u20136.","journal-title":"Arthritis Rheum"},{"key":"9171_CR22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1196\/annals.1398.012","volume":"1109","author":"A Melegari","year":"2007","unstructured":"Melegari A, Mascia MT, Sandri G, Carbonieri A. Immunodeficiency and autoimmune phenomena in female hyper-IgM syndrome. Ann N Y Acad Sci 2007;1109:106\u20138.","journal-title":"Ann N Y Acad Sci"},{"key":"9171_CR23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2003.10.007","volume":"110","author":"P Quartier","year":"2004","unstructured":"Quartier P, Bustamante J, Sanal O, Plebani A, Debr\u00e9 M, Deville A, et al. Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to activation-induced cytidine deaminase deficiency. Clin Immunol 2004;110:22\u20139. Erratum in: Clin Immunol. 113:220, 2004.","journal-title":"Clin Immunol"},{"key":"9171_CR24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.0105-2896.2005.00221.x","volume":"203","author":"JS Orange","year":"2005","unstructured":"Orange JS, Levy O, Geha RS. Human disease resulting from gene mutations that interfere with appropriate nuclear factor-kappaB activation. Immunol Rev 2005;203:21\u201337.","journal-title":"Immunol Rev"},{"key":"9171_CR25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4049\/jimmunol.166.1.353","volume":"166","author":"A Kumanogoh","year":"2001","unstructured":"Kumanogoh A, Wang X, Lee I, Watanabe C, Kamanaka M, Shi W, et al. Increased T cell autoreactivity in the absence of CD40\u2013CD40 ligand interactions: a role of CD40 in regulatory T cell development. J Immunol 2001;166:353\u201360.","journal-title":"J Immunol"},{"issue":"87","key":"9171_CR26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0092-8674(00)81349-5","volume":"18","author":"JC Rathmell","year":"1996","unstructured":"Rathmell JC, Townsend SE, Xu JC, Flavell RA, Goodnow CC. Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 1996;18(87):319\u201329.","journal-title":"Cell"},{"key":"9171_CR27","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/art.1780401002","volume":"40","author":"SK Datta","year":"1997","unstructured":"Datta SK, Kalled SL. CD40\u2013CD40 ligand interaction in autoimmune disease. Arthritis Rheum 1997;40:1735\u201345.","journal-title":"Arthritis Rheum"},{"key":"9171_CR28","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1172\/JCI118643","volume":"97","author":"A Desai-Mehta","year":"1996","unstructured":"Desai-Mehta A, Lu L, Ramsey-Goldman R, Datta SK. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 1996;97:2063\u201373.","journal-title":"J Clin Invest"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-008-9171-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-008-9171-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-008-9171-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T06:36:04Z","timestamp":1684218964000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-008-9171-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,2]]},"references-count":28,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["9171"],"URL":"https:\/\/doi.org\/10.1007\/s10875-008-9171-x","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,2]]}}}